Poseida Therapeutics, Inc.

PSTX · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$44,472$81,378$206,325$83,966
Short-Term Investments$167,730$201,115$0$225,186
Receivables$9,010$9,088$0$0
Inventory$0$0$0$0
Other Curr. Assets$5,263$6,982$7,548$4,844
Total Curr. Assets$226,475$298,563$213,873$313,996
Property Plant & Equip (Net)$40,781$46,671$48,227$48,322
Goodwill$4,228$4,228$4,228$4,228
Intangibles$1,320$1,320$1,320$1,320
Long-Term Investments$0-$9,224-$8,926-$9,125
Tax Assets$0$9,224$8,926$9,125
Other NC Assets$1,081$1,055$1,661$3,618
Total NC Assets$47,410$53,274$55,436$57,488
Other Assets$0$0$0$0
Total Assets$273,885$351,837$269,309$371,484
Liabilities
Payables$3,267$2,228$8,961$763
Short-Term Debt$5,951$5,866$12,674$9,616
Tax Payable$0$0$0$0
Deferred Revenue$31,008$19,723$4,497$22,615
Other Curr. Liab.$31,092$26,068$17,203$19,646
Total Curr. Liab.$71,318$53,885$43,335$30,025
LT Debt$79,472$82,886$80,365$54,507
Deferred Rev, NC$16,780$21,333$9,265$23,755
Deferred Tax Liab, NC$0$55$55$55
Other NC Liab.$2,614$6,083-$19,922$24,929
Total NC Liab.$98,866$110,357$69,763$79,491
Other Liabilities$0$0$0$0
Cap. Leases$26,833$30,502$31,841$30,182
Total Liabilities$170,184$164,242$113,098$109,516
Equity
Pref Stock$0$0$0$0
Common Stock$10$9$6$6
Retained Earnings-$594,291-$470,861-$406,859-$281,885
AOCI$126-$149$0$5
Other Equity$697,856$658,596$563,064$543,842
Total Equity$103,701$187,595$156,211$261,968
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$273,885$351,837$269,309$371,484
Net Debt$40,951$7,374-$113,286-$19,843